title: Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1beta expression.
abstract: Interleukin (IL)-1beta is a proinflammatory cytokine implicated in several neurodegenerative disorders. Downstream actions of IL-1beta include production of prostaglandin (PG) E(2) by increasing expression of cyclooxygenase (COX) enzymes and prostaglandin E synthase (PGES) isoforms. We recently developed a transgenic mouse carrying a dormant human IL-1beta eXcisional Activation Transgene (XAT) for conditional and chronic up-regulation of IL-1beta in selected brain regions. This model is characterized by regionally specific glial activation, immune cell recruitment, and induction of cytokines and chemokines. Here, we aimed to elucidate the effects of long-term IL-1beta expression on the PGE(2) synthetic pathway and to determine the effects of PGs on inflammation and memory in our model. As expected, PGE(2) levels were significantly elevated after IL-1beta up-regulation. Quantitative real-time PCR analysis indicated significant induction of mRNAs for COX-1 and membranous PGES-1, but not COX-2 or other PGES isoforms. Immunohistochemistry revealed elevation of COX-1 but no change in COX-2 following sustained IL-1beta production. Furthermore, pharmacological inhibition of COX-1 and use of COX-1 knockout mice abrogated IL-1beta-mediated PGE(2) increases. Although COX-1 deficient mice did not present a dramatically altered neuroinflammatory phenotype, they did exhibit improved contextual fear memory. This data suggests a unique role for COX-1 in mediating chronic neuroinflammatory effects through PGE(2) production.
authors.affiliation: Department of Neurobiology and Anatomy, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
authors.forename: Sarah B
authors.initials: SB
authors.lastname: Matousek
authors.forename: Amy M
authors.initials: AM
authors.lastname: Hein
authors.forename: Solomon S
authors.initials: SS
authors.lastname: Shaftel
authors.forename: John A
authors.initials: JA
authors.lastname: Olschowka
authors.forename: Stephanos
authors.initials: S
authors.lastname: Kyrkanides
authors.forename: M Kerry
authors.initials: MK
authors.lastname: O'Banion
mesh_terms: D000818:Animals; D051545:Cyclooxygenase 1 / Q000235:genetics / Q000502:physiology*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000378:metabolism*; D005239:Fear; D006624:Hippocampus / Q000378:metabolism*; D006801:Humans; D053583:Interleukin-1beta / Q000096:biosynthesis* / Q000235:genetics; D008568:Memory; D051379:Mice; D008822:Mice, Transgenic; D023421:Models, Animal
chemical_list: D016861:Cyclooxygenase Inhibitors; D053583:Interleukin-1beta; D051545:Cyclooxygenase 1; D015232:Dinoprostone
references.citation: Brain Res. 2005 Mar 21;1038(2):231-7
references.pmid: 15757639
references.citation: Pharmacol Rep. 2007 Mar-Apr;59(2):164-72
references.pmid: 17556794
references.citation: Toxicol Appl Pharmacol. 2009 Jul 1;238(1):64-70
references.pmid: 19397918
references.citation: J Neurochem. 2005 Jun;93(6):1561-7
references.pmid: 15935072
references.citation: J Neurochem. 2005 Apr;93(2):403-11
references.pmid: 15816863
references.citation: J Neuroimmunol. 2004 Mar;148(1-2):32-40
references.pmid: 14975584
references.citation: J Neurotrauma. 1998 Dec;15(12):1005-13
references.pmid: 9872457
references.citation: Mol Neurobiol. 2009 Aug;40(1):15-32
references.pmid: 19365736
references.citation: Prostaglandins Other Lipid Mediat. 2003 Jul;71(3-4):205-16
references.pmid: 14518562
references.citation: FASEB J. 2008 May;22(5):1491-501
references.pmid: 18162486
references.citation: Neurobiol Aging. 2007 May;28(5):639-47
references.pmid: 16697488
references.citation: Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):307-15
references.pmid: 15975032
references.citation: Acta Neuropathol. 2000 Jun;99(6):609-14
references.pmid: 10867793
references.citation: J Neurosurg. 2002 May;96(5):892-9
references.pmid: 12005397
references.citation: Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2317-21
references.pmid: 8637870
references.citation: Brain Behav Immun. 2010 Mar;24(3):409-19
references.pmid: 19931610
references.citation: J Clin Invest. 2007 Jun;117(6):1595-604
references.pmid: 17549256
references.citation: Neurology. 2008 May 6;70(19):1672-7
references.pmid: 18458226
references.citation: Brain Behav Immun. 1998 Sep;12(3):212-29
references.pmid: 9769157
references.citation: BMC Neurosci. 2009 Aug 31;10:108
references.pmid: 19719848
references.citation: Ann Neurol. 2003 Aug;54(2):155-62
references.pmid: 12891667
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20979-84
references.pmid: 18077391
references.citation: Br J Pharmacol. 2006 Jan;147 Suppl 1:S232-40
references.pmid: 16402109
references.citation: Prostaglandins. 1997 Sep;54(3):601-24
references.pmid: 9373877
references.citation: Neurobiol Aging. 1999 May-Jun;20(3):305-13
references.pmid: 10588578
references.citation: J Neuropathol Exp Neurol. 1999 Nov;58(11):1135-46
references.pmid: 10560656
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10954-9
references.pmid: 9724811
references.citation: J Neuroimmunol. 2006 May;174(1-2):39-51
references.pmid: 16529823
references.citation: J Neurochem. 1996 Jun;66(6):2532-40
references.pmid: 8632179
references.citation: Brain Behav Immun. 2010 Feb;24(2):243-53
references.pmid: 19825412
references.citation: JAMA. 2003 Jun 4;289(21):2819-26
references.pmid: 12783912
references.citation: Brain Res. 2008 May 1;1207:225-36
references.pmid: 18374906
references.citation: J Neurosci Res. 2004 Oct 15;78(2):151-6
references.pmid: 15378607
references.citation: Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):113-7
references.pmid: 19393332
references.citation: J Neurosci. 2007 Aug 29;27(35):9301-9
references.pmid: 17728444
references.citation: Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):267-72
references.pmid: 15850932
references.citation: J Comp Neurol. 1995 May 1;355(2):296-315
references.pmid: 7608344
references.citation: Neuropharmacology. 2004 Jun;46(8):1195-200
references.pmid: 15111026
references.citation: Neurochem Int. 2007 Jul-Sep;51(2-4):112-20
references.pmid: 17629358
references.citation: J Neurochem. 2006 Aug;98(3):801-11
references.pmid: 16787416
references.citation: Neuroscience. 2007 Dec 19;150(4):754-63
references.pmid: 18035502
references.citation: Neurobiol Aging. 2001 Nov-Dec;22(6):823-36
references.pmid: 11754989
references.citation: Brain Res Mol Brain Res. 2002 Aug 15;104(2):159-69
references.pmid: 12225870
references.citation: Ann Neurol. 2006 Jul;60(1):22-31
references.pmid: 16802291
references.citation: Pharmacol Biochem Behav. 2008 May;89(3):404-11
references.pmid: 18295322
references.citation: Crit Rev Neurobiol. 1999;13(1):45-82
references.pmid: 10223523
references.citation: J Neuroimmunol. 2000 Jul 1;106(1-2):198-205
references.pmid: 10814798
references.citation: Trends Pharmacol Sci. 2009 Apr;30(4):174-81
references.pmid: 19269697
references.citation: Exp Brain Res. 2002 Nov;147(2):193-9
references.pmid: 12410334
references.citation: Neuroscience. 2009 Dec 29;164(4):1484-95
references.pmid: 19744544
references.citation: J Neurochem. 2003 Aug;86(3):545-55
references.pmid: 12859668
references.citation: Radiat Res. 2004 Feb;161(2):153-60
references.pmid: 14731075
references.citation: Brain Res. 1993 Jun 4;613(1):160-3
references.pmid: 8348300